J Clin Transl Sci
. 2023 Oct 31;7(1):e221.
doi: 10.1017/cts.2023.644. eCollection 2023.
ACTIV-6: Operationalizing a decentralized, outpatient randomized platform trial to evaluate efficacy of repurposed medicines for ...
Announcement
Collapse
No announcement yet.
Search Result
Collapse
263 results in 0.0650 seconds.
Keywords
Members
Tags
-
tetano started a topic J Clin Transl Sci . ACTIV-6: Operationalizing a decentralized, outpatient randomized platform trial to evaluate efficacy of repurposed medicines for COVID-19in TreatmentsJ Clin Transl Sci . ACTIV-6: Operationalizing a decentralized, outpatient randomized platform trial to evaluate efficacy of repurposed medicines for COVID-19
-
CIDRAP- NEWS BRIEFS November 17, 2023
https://www.cidrap.umn.edu/all-news
Study shows modest flu vaccine protection against serious disease in kids last season
News brief
42 minutes ago.
Stephanie Soucheray, MA
Topics
...
-
WHO updates guidelines on treatments for COVID-19. 10 November 2023
10 November 2023
Statement
Geneva, Switzerland
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated...
-
CIDRAP- NEWS BRIEFS November 10, 2023
https://www.cidrap.umn.edu/all-news
WHO updates COVID treatment guidelines, risk estimates for hospitalization
News brief
Today at 2:40 p.m.
Mary Van Beusekom, MS
Topics
COVID-19...
-
tetano started a topic Clin Epidemiol . Efficacy and Safety of Novel Oral Antivirals in Hospitalized COVID-19 Patients: A Network Meta-Analysis of Randomized Clinical Trialsin TreatmentsClin Epidemiol . Efficacy and Safety of Novel Oral Antivirals in Hospitalized COVID-19 Patients: A Network Meta-Analysis of Randomized Clinical Trials
Clin Epidemiol
. 2023 Nov 1:15:1041-1053.
doi: 10.2147/CLEP.S422386. eCollection 2023. Efficacy and Safety of Novel Oral Antivirals in Hospitalized COVID-19 Patients: A Network Meta-Analysis of Randomized Clinical Trials...
-
CIDRAP- NEWS BRIEFS November 1, 2023
https://www.cidrap.umn.edu/all-news
US survey reveals growing distrust of vaccines, embrace of untruths
News brief
31 minutes ago.
Mary Van Beusekom, MS
Topics
Anti-science
...
-
CIDRAP- NEWS BRIEFS October 2, 2023
https://www.cidrap.umn.edu/all-news
Study: 1 in 20 Americans used non-evidence based COVID treatments
News brief
Today at 3:07 p.m.
Stephanie Soucheray, MA
Topics
COVID-19
SHARE...
-
tetano started a topic Open Forum Infect Dis . The Penn Medicine COVID-19 Therapeutics Committee-Reflections on a Model for Rapid Evidence Review and Dynamic Practice Recommendations During a Public Health Emergencyin PreparednessOpen Forum Infect Dis . The Penn Medicine COVID-19 Therapeutics Committee-Reflections on a Model for Rapid Evidence Review and Dynamic Practice Recommendations During a Public Health Emergency
Open Forum Infect Dis
. 2023 Aug 9;10(8):ofad428.
doi: 10.1093/ofid/ofad428. eCollection 2023 Aug. The Penn Medicine COVID-19 Therapeutics Committee-Reflections on a Model for Rapid Evidence Review and Dynamic Practice Recommendations...
-
Lance started a topic CIDRAP- Report spotlights 52 US doctors who posted potentially harmful COVID misinformation onlinein CIDRAPCIDRAP- Report spotlights 52 US doctors who posted potentially harmful COVID misinformation online
https://www.cidrap.umn.edu/covid-19/...rmation-online
Report spotlights 52 US doctors who posted potentially harmful COVID misinformation online
...
-
tetano started a topic Virol J . Patch-clamp studies and cell viability assays suggest a distinct site for viroporin inhibitors on the E protein of SARS-CoV-2in TreatmentsVirol J . Patch-clamp studies and cell viability assays suggest a distinct site for viroporin inhibitors on the E protein of SARS-CoV-2
Virol J
. 2023 Jul 8;20(1):142.
doi: 10.1186/s12985-023-02095-y. Patch-clamp studies and cell viability assays suggest a distinct site for viroporin inhibitors on the E protein of SARS-CoV-2
Ulrike Breitinger 1...
-
CIDRAP- Common diabetes drug shown to prevent long COVID
https://www.cidrap.umn.edu/covid-19/...ent-long-covid
Common diabetes drug shown to prevent long COVID
Stephanie Soucheray, MA
Today at 2:44 p.m.
COVID-19 A 14-day...
-
Mary Wilson started a topic Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial - The Lancetin TreatmentsOutpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial - The Lancet
Published: June 08, 2023
DOI: https://doi.org/10.1016/S1473-3099(23)00299-2
Carolyn T Bramante, MD, Prof John B Buse, PhD, David M Liebovitz, MD, Jacinda M Nicklas, MD, Michael A Puskarich, MD, Ken Cohen, MD, et al.
...
-
https://johninengland.substack.com/p...medium=reader2
My banned video with Dr. Pierre Kory
The full video on Substack
John Campbell
May 31,...
-
Ivermectin - A useful treatment for COVID-19 coronavirus? Some discussion and studies...
I found this recent review on ivermectin data, which looks interesting and appears to have some very positive data behind it, albeit a lot of it is pre full publication.. However, I suspect that as it is a generic and not licensed or produced in some...
Leave a comment: